from American Cancer Society
Current guidelines for using aspirin to prevent disease consider only its cardiovascular benefits and reducing the risk of colorectal cancer and weigh those benefits against the potential harm caused by risk of bleeding. However, a new report by the American Cancer Society suggests daily use of aspirin, even at low doses, may also reduce the incidence of all cancers. It concludes that even a ten percent reduction in overall cancer incidence could tip the balance of benefits and risks favorably. In six primary prevention studies of daily low-dose aspirin, aspirin treatment was associated with approximately twenty percent fewer cases of cancer within three to five years after starting the treatment. Not everybody is a candidate for daily aspirin use, so discuss it with your doctor first.